Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zelquistinel (GATE-251) / Gate Neurosciences
NCT06547489: GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Recruiting	2	164	US	Zelquistinel, GATE-251	Gate Neurosciences, Inc, Worldwide Clinical Trials	Major Depressive Disorder	08/26	12/26